Head and Neck Cancer. Mukund Seshadri DDS, PhD.!
|
|
- Charlotte Small
- 5 years ago
- Views:
Transcription
1 Head and Neck Cancer Mukund Seshadri DDS, PhD
2 Overview Epidemiology Etiology and Risk factors Disease Biology Management Conventional Novel Targeted Therapies Treatment- related complications Impact of HPV
3 Anatomy Head and Neck Cancers rmgmed.com Sixth most common cancer world wide Annual global incidence ~600,000 cases Oral cavity (lips, tongue, palate, floor of the mouth, buccal mucosa) Pharynx (nasopharynx, oropharynx, hypopharynx) Larynx Salivary glands Sinuses Ear (external auditory canal) Biologically heterogeneous group of cancers
4 Epidemiology Incidence of ~54,000 in the US (~3% of all cancers) ~12,000 deaths annually in the US Diagnosed more often in people over 50 but Epidemiology of the disease is changing Siegel et al, 2014
5 Epidemiology High incidence areas of central Asia and the Indian sub- continent Eastern Europe and the former Soviet republics have high mortality (low socio- economic status, limited treatment facilities) Papua New Guinea and surrounding melanesian islands of the Western Pacific are in the top quintile both in incidence and mortality Johnson and Amarasinghe, J Bernier Head and Neck Cancer: Multimodality Management
6 Etiology and Risk factors Tobacco Single most important risk factor Cigarettes, pipe, smokeless tobacco (chew, snuff, betel quid) Increased risk of HNC in smokers (5-20 fold> non- smokers) Warnakulasuriya et al. 2005
7 Alcohol Etiology and Risk factors Second most common risk factor Association is stronger for pharyngeal cancer Tobacco and alcohol - synergistic effects on risk of HNC ACS Atlas of the Head and Neck Jatin Shah
8 Viral infection Etiology and Risk factors EBV nasopharyngeal carcinoma HIV HPV Occupational exposure Radiation Diet Genetic factors Scully & Bagan, 2009
9 HPV- associated Head and Neck Cancers Oropharynx Increasing incidence in US, Canada, Australia and Japan A developed country phenomenon Rising incidence in young males Reason: Change in sexual behaviors Male predominence Efficiency of transmission through oral sex? Marur et al., 2010 Chaturvedi et al., NCI
10 Head and Neck Carcinogenesis Forastiere et al., 2001
11 Head and Neck Carcinogenesis Field cancerization and local relapse Presence of one or more mucosal areas consisting of epithelial cells that have cancer- associated genetic or epigenetic alterations Leemans et al., 2011
12 Premalignant lesions Premalignant lesions - Leukoplakia - Erythroplakia - Lichenoid lesions - Submucous fibrosis Erythroplakias have increased risk of progression to carcinoma Immediate need for diagnostic tools to identify dysplasia in relation to progression Hunter et al., 2005
13 Pathology of Head and Neck Cancers Carcinoma in situ ACS Atlas of the Head and Neck Jatin Shah
14 Pathology of Head and Neck Cancers Majority (~75%) are squamous cell carcinomas Moderately diff SCC ACS Atlas of the Head and Neck Jatin Shah
15 Pathology of Head and Neck Cancers Salivary glands ACS Atlas of the Head and Neck Jatin Shah
16 Perineural Invasion in SGC Cancer cell invasion in, around and through nerves or the finding of tumor cells within any of the the layers (epineurium, perineurium, endoneurium) of the nerve sheath. ACCs and SDCs exhibit high degree of PNI; SCCs also exhibit PNI frequently. Indicator of aggressive behavior and independent prognostic factor in ACC Johnston et al 2012
17 Clinical evaluation Evaluation of suspicious oral lesions Williams et al 2008
18 Clinical evaluation Appearances of oral premalignant and early cancer smooth, white, homogeneous red, diffuse, granular lesion; diffuse, red ulcerated lesion diffuse, raised,speckled, indurated lesion Williams et al 2008
19 Autofluorescence imaging Clinical evaluation Visualization of a diffuse, nodular erythro- leukoplakia at the right lateral ventral tongue Moderate-severe dysplasia Williams et al 2008
20 Diagnosis/Staging of HNC Biopsy Essential for diagnosis of malignancy FNA nodal disease, parotid, thyroid lesions, TNM classification Combination of histopathologic/radiologic assessment Standardized classification system
21 TNM Classification T tumor size, location, extent N lymph node involvement (size, side) M metastases American Joint Committee on Cancer, Cancer Staging
22 Diagnosis/Staging of HNC Lymph node distribution of the head and neck region Critical component of the clinical examination Marur et al, Mayo Clin Proc 2008
23 Staging of HNC Describes the severity of an individual's cancer based on the magnitude of the original (primary) tumor as well as on the extent cancer has spread in the body Clinical Staging - based on physical examination, imaging tests, and biopsies. Pathologic Staging - Combines the results of clinical staging with pathologic examination of surgical tissue Post- Therapy or Post- Neoadjuvant Therapy Staging - determines how much cancer remains after a patient is first treated with systemic (chemotherapy or hormone therapy) and/or radiation therapy prior to their surgery or where no surgery is performed. This can be assessed by clinical staging guidelines and/ or pathologic staging guidelines. Restaging is used to determine the extent of the disease if a cancer comes back after treatment. Restaging helps determine the and the best treatment options for cancer that has returned. American Joint Committee on Cancer, Cancer Staging
24 Staging of HNC TNM staging system allows clinicians to categorize tumors of the head and neck region in a specific manner to assist with the assessment of disease status, prognosis, and management. Deschler and Day, TNM Staging of Head and Neck Cancer
25 Radiologic assessment Plain X- ray Panorex bone invasion - mandible Chest small lesions CT bone involvement, cystic nodal metastasis (CT with contrast) MRI soft tissue (extent of tumor, bone invasion, vascular involvement) PET - metastatic survey
26 Management of Head and Neck Cancer NCCN Guidelines 2011
27 Management of Head and Neck Cancer SUPPORTIVE SERVICES NCCN Guidelines 2011
28 Primary Therapy Decision Making Surgery, Chemotherapy and Radiation (+/- Targeted Therapy) Patient status Age, debility, pulmonary status, medical co- morbidities psychological status, motivation, family support, rehab potential Primary Tumor Anatomic site, tumor volume, extent (PNI, bone invasion etc), field cancerization Anticipated cosmetic and functional sequelae QOL Prior therapy ACS Atlas of the Head and Neck Jatin Shah
29 Optimizing the Therapeutic Ratio in HNC Balance between disease control and toxicity Corry et al 2010
30 Management of Head and Neck Cancer Surgery Oral cavity Primary treatment Eliminates risk of ORN (complication of RT) Larynx Organ preservation/conservative laryngeal procedures can preserve voice Salivary gland tumors Surgery + post- operative RT for high- grade lesions Thyroid Total thyroidectomy NCCN Guidelines 2011
31 Management of Head and Neck Cancer Lymph nodes Surgery Drainage of oral cavity into extensive number of lymph nodes in the neck Neck is divided into 6 surgical levels Selective or radical neck dissection depending on stage (lymph node involvement) ACS Atlas of the Head and Neck Jatin Shah
32 Management of Head and Neck Cancer Radiation Therapy Can be pre- operative or post- operative Pre- operative RT Patients can undergo rigorous supportive therapy prior to surgery Control of sub- clinical disease at the primary site Typically given 5 days a week ( cgy; total of cgy) Post- operative RT Risk of locoregional recurrence - improved local control Advanced lesions Positive margins PNI/vascular invasion No delay in surgery, sterilization of residual microscopic disease
33 Management of Head and Neck Cancer Chemotherapy Platinum analogues Cisplatin, carboplatin Bind to DNA à s/ds breaks Taxanes Microtubule inhibitor cell cycle arrest 5- Fluorouracil Thymidylate synthase inhibition (DNA damage)
34 Management of Head and Neck Cancer The Concurrent ChemoRT paradigm Siewert et al., 2007
35 Management of Head and Neck Cancer The Concurrent ChemoRT paradigm Siewert et al., 2007
36 Molecular Pathogenesis of HNC EGFR pathway Leemans et al., 2011 Ciardiello & Tortora, 2008
37 Targeted Therapies for HNSCC EGFR inhibitors Cetuximab monoclonal antibody against EGFR First targeted agent to be approved for HNC Ciardiello & Tortora, 2008
38 Management of Head and Neck Cancer Anti- EGFR therapy + Radiation Treatment of locoregionally advanced head and neck cancer with concomitant high- dose radiotherapy plus cetuximab improves locoregional control and reduces mortality without increasing the common toxic effects associated with radiotherapy to the head and neck. Bonner et al., 2006
39 Management of Head and Neck Cancer Anti- EGFR therapy + chemotherapy On November 7, 2011 the U.S.FDA approved cetuximab in combination with cisplatin or carboplatin and 5- fluorouracil for the first- line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer. The median overall survival was 10.1 months (95% CI: ) for the cetuximab/ chemotherapy arm compared to 7.4 months (6.4, 8.3) for the chemotherapy alone arm (stratified log- rank p.035). Cohen et al., 2013
40 Antiangiogenic Therapies in HNSCC Klein et al 2010
41 Treatment complications Scully/Bagan 2009
42 Treatment complications Mucositis (complication of RT) Inflammation and ulceration of the mucosal lining of the mouth, pharynx, esophagus and GI tract due to the direct cytotoxic effects on the epithelial cells - Painful, affects QOL - Management: Mouth rinses, anti- fungal agents Xerostomia (dry mouth) Effect of RT on salivary glands Management salivary substitutes, Dental management - prevention of caries, fluoride gels Osteoradionecrosis Non- vital bone in a site of radiation injury; related to radiation PreRT dental evaluation is imperative to minimize risk of ORN Supportive therapy, HBO therapy, microvascular reconstruction
43 Prognosis Clinical impact and Biological Mechanisms of HPV- associated HNSCC
44 HPV- associated Head and Neck Cancers Human papilloma virus DNA viruses with tropism for squamous epithelia High- risk oncogenic types: HPV16,- 18,- 31-,33,- 35 Rautava- Syrjanen, 2012
45 HPV & Carcinogenesis The E6 protein binds p53 and targets the protein for degradation, whereas the E7 protein binds and inactivates the Rb pocket proteins. The molecular consequence of the expression of these viral oncoproteins is cell cycle entry and inhibition of p53- mediated apoptosis, which allows the virus to replicate. Leemans et al., 2011
46 HPV Positive Vs. HPV Negative HNSCC Marur et al., 2010 Leemans et al., 2011
47 HPV- associated Head and Neck Cancers HPV- positive HNSCC Typically well defined borders Axial contrast- enhanced CT image showing midline base of tongue mass with well- defined margins and nodal metastases Cantrell et al., 2013
48 HPV- associated Head and Neck Cancers HPV- negative HNSCC Deep muscular invasion involving the extrinsic muscles of the tongue with submucosal spread Axial contrast- enhanced CT image showing a large and deeply invasive T4 base of tongue lesion, extending anteriorly into the oral tongue. Cantrell et al., 2013
49 Prognostic Impact of HPV in HNSCC ECOG Phase II trial (Stage III or IV HNSCC) HNSCC HPV positive HPV negative OPC Patients with HPV- positive tumors had higher response rates compared to patients with HPV- negative tumors after induction chemotherapy (82% vs 55%) and after chemoradiation treatment (84% vs 57%) Fakhry et al., 2008
50 Prognostic Impact of HPV in HNSCC RTOG 0128 Strong and independent prognostic factor for survival among patients with oropharyngeal cancer Ang et al., 2010
51 Prognostic Impact of HPV in HNSCC Summary of Clinical Evidence For patients with HNSCC of the oropharynx, tumor HPV status is strongly associated with therapeutic response and survival Langer, 2012
52 Impact of HPV on Targeted Therapies p16 and HPV status have prognostic value in R/M SCCHN and survival benefits of chemotherapy plus cetuximab over chemotherapy alone are independent of tumor p16 and HPV status. Vermorken et al., 2014
53 HPV- associated Head and Neck Cancers Biological mechanisms Possible reasons for the improved survival - Increased sensitivity to chemo/rad - Immune surveillance to viral antigens - Absence of field cancerization in these patients who tend to be nonsmokers - HPV- positive tumors may have an intact apoptotic response to radiation and chemotherapy (functional inactivation may not be similar to p53 mutation). Fakhry et al., 2006 Marur et al., 2010
54 HPV- associated Head and Neck Cancers Biological mechanisms HPV+ cells exhibit enhanced sensitivity to radiation Low levels of normal functioning p53 in HPV+HNC could be activated by radiation Kimple et al., 2013
55 HPV- associated Head and Neck Cancers Biological mechanisms Kimple et al., 2013 Inactivation of the p53 and prb pathways is a common event in the molecular progression of HNSCC but occurs by different mechanisms in HPV+ and HPV- tumors. HPV- positive tumors Tend to have wild- type p53 because p53 is functionally inactivated by viral E6 oncoprotein HPV- negative tumors have specific p53 mutations demonstrated to be induced by carcinogens in tobacco Fakhry et al., 2006
56 HPV- associated Head and Neck Cancers Biological mechanisms Troy et al., 2013
57 HPV- associated Head and Neck Cancers Biological mechanisms Kostareli et al., 2012
58 Therapeutic Impact of HPV- related HNC - HPV+ and HPV- cancers are discrete cancers with differing biology. - Current HNSCC treatments have a severe impact on QOL - - Can treatment intensity be personalized by HPV status? Treatment de- intensification to reduce acute toxicity and improve patient recovery? - Selection of patients for organ preservation therapy Need to identify new approaches to treat HPV- negative HNSCC Chung and Schwartz, 2012
59 HPV- associated Head and Neck Cancers Implications for Prevention A male phenomenon No change in incidence of HPV- related cancers in women Growing burden of younger patients with good performance status and superior survival Male vaccination? Chaturvedi et al., NCI Marur et al., 2010
60 Head and neck cancers Concluding remarks Biologically heterogeneous group of cancers Management is complex and interdisciplinary Understand the role of HPV and its clinical implications The need for early detection and chemoprevention strategies Kostareli et al., 2012
Head and Neck Cancer. Mukund Seshadri DDS, PhD.!
Head and Neck Cancer Mukund Seshadri DDS, PhD Mukund.Seshadri@roswellpark.org 716-845- 1552 Overview Epidemiology Etiology and Risk factors Disease Biology Management Conventional Novel Targeted Therapies
More informationHead and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.
Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S. Associate Professor Division of Head and Neck Surgery Department of Otolaryngology-Head and
More informationEvaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S.
Evaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S. Residency Site Director Weill Cornell Medical Center Associate Professor Division of Head
More informationAdjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support
Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no
More information3/12/2018. Head & Neck Cancer Review INTRODUCTION
Head & Neck Cancer Review Joseph Rosales, MD March 12, 2018 INTRODUCTION Epidemiology/Risk Factors Anatomy Presentation/Workup Treatment Surgery vs Radiation Chemotherapy Side effects Special circumstances
More informationRADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.
RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1. 550 000 NEW PATIENTS/YEAR WITH HEAD AND NECK CANCER ALL
More informationDiseases of oral cavity
Diseases of oral cavity Diseases of Teeth and Supporting Structures Inflammatory/Reactive Lesions Infections Oral Manifestations of Systemic Disease Precancerous and Cancerous Lesions Odontogenic Cysts
More informationHPV and Head and Neck Cancer: What it means for you and your patients
HPV and Head and Neck Cancer: What it means for you and your patients Financial Disclosure: None November 8, 2013 Steven J. Wang, MD Associate Professor Department of Otolaryngology-Head and Neck Surgery
More informationClinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital
Clinical Discussion Dr Pankaj Chaturvedi Professor and Surgeon Tata Memorial Hospital chaturvedi.pankaj@gmail.com 47/M/smoker Hopkins : Transglottic lesion No cartilage infiltration but sclerosis Left
More informationDisclosures. HPV and Head and Neck Cancer NONE 5/8/2018
Bill Lydiatt, MD EMBA Chair Department of Surgery Methodist Hospital Clinical Professor of Surgery Creighton University HPV and Head and Neck Cancer Disclosures NONE 1 OVERVIEW Traditional Head and Neck
More informationFINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma
Case Scenario 1 HNP: A 70 year old white male presents with dysphagia. The patient is a current smoker, current user of alcohol and is HPV positive. A CT of the Neck showed mass in the left pyriform sinus.
More informationDe-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist
De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to
More informationOral Cancer Dr Christine Goodall Consultant Oral Surgeon University of Glasgow Dental School
Oral Cancer Dr Christine Goodall Consultant Oral Surgeon University of Glasgow Dental School christine.goodall@glasgow.ac.uk Locations Lip, mouth, oropharynx Tongue, floor of mouth, buccal mucosa, palate,
More informationSAMO MASTERCLASS HEAD & NECK CANCER. Nicolas Mach, PD Geneva University Hospital
SAMO MASTERCLASS HEAD & NECK CANCER Nicolas Mach, PD Geneva University Hospital Epidemiology Prevention Best treatment for localized disease Best treatment for relapsed or metastatic disease Introduction
More informationCarcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY
Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY SEARCHING FOR THE PRIMARY? P r o f J P P r e t o r i u s H e a d : C l i n i c a l U n i t C r i t i c a l C a r e U n i v e r s i t y O f
More informationClinical Policy: Cetuximab (Erbitux) Reference Number: PA.CP.PHAR.317
Clinical Policy: (Erbitux) Reference Number: PA.CP.PHAR.317 Effective Date: 01/18 Last Review Date: 11/17 Coding Implications Revision Log Description The intent of the criteria is to ensure that patients
More informationOral Cancer and Common Oral Lesions seen in HIV Seropositive Patients. Gwen Cohen Brown DDS, FAAOMP Professor New York City College of Technology
Oral Cancer and Common Oral Lesions seen in HIV Seropositive Patients Gwen Cohen Brown DDS, FAAOMP Professor New York City College of Technology Program Objectives Recognize the oral health needs of the
More informationHead and Neck Squamous Subtypes
1 Head and Neck Squamous Subtypes Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas HNSCC 5 th -6 th most common cancer 400,000/year 50% mortality Considerable
More informationMANAGEMENT OF CA HYPOPHARYNX
MANAGEMENT OF CA HYPOPHARYNX GENERAL TREATMENT RECOMMENDATIONS BASED ON HYPOPHARYNX TUMOR STAGE For patients presenting with early-stage definitive radiotherapy alone or voice-preserving surgery are viable
More informationPre- Versus Post-operative Radiotherapy
Postoperative Radiation and Chemoradiation: Indications and Optimization of Practice Dislosures Clinical trial support from Genentech Inc. Sue S. Yom, MD, PhD Associate Professor UCSF Radiation Oncology
More informationCancer of the Oral Cavity
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology Cancer of the Oral Cavity Ashok Shaha Principals of Management of Oral Cancer A)
More informationHPV-Related Head and Neck Squamous Cancers
2015 Wisconsin Comprehensive Cancer Control Summit Aligning Partners, Priorities, and the Plan HPV-Related Head and Neck Squamous Cancers MCW Department of Otolaryngology and Communication Sciences MCW
More informationOral Cancer FAQs. What is oral cancer? How many people are diagnosed with oral cancer each year?
Oral Cancer FAQs What is oral cancer? Oral cancer or oral cavity cancer, is cancer that starts in the mouth. Areas affected by this type of cancer are the lips, the inside lining of the lips and cheeks
More informationObjectives. HPV Classification. The Connection Between Human Papillomavirus and Oropharyngeal Cancer 6/19/2012
The Connection Between Human Papillomavirus and Oropharyngeal Cancer Jennifer L. Cleveland, DDS, MPH Dental Officer/Epidemiologist OSAP Annual Symposium June 23, 2012 Atlanta, GA National Center for Chronic
More informationOral Cancer. Online Course:
Continuing Education Brought to you by Oral Cancer Course Author(s): Richard C. Jordan, DDS, PhD, FRCD(C) FRCPath CE Credits: 1 hour Intended Audience: Dentists, Dental Hygienists, Dental Assistants, Dental
More informationOral Cancer Risk and Detection
Oral Cancer Risk and Detection Evan M. Graboyes, MD Assistant Professor Department of Otolaryngology-Head & Neck Surgery Cancer Control Program, Hollings Cancer Center Medical University of South Carolina
More informationLong Term Toxicities of Head & Neck Cancer Therapies. Faith Mutale Abramson Cancer Center University of Pennsylvania
Long Term Toxicities of Head & Neck Cancer Therapies Faith Mutale Abramson Cancer Center University of Pennsylvania Head & Neck Cancer 2-3% of all cancers 1-2% of all cancer deaths Incidence includes:
More informationHead and Neck Cancer:
Head and Neck Cancer: Robert Haddad M.D. Clinical Director Head and Neck Oncology Program Dana Farber Cancer Institute Boston, MA Predictive Biomarkers: HPV Abstract 6003: Survival Outcomes By HPV Status
More informationNICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36
Cancer of the upper aerodigestive e tract: assessment and management in people aged 16 and over NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36 NICE 2018. All rights reserved. Subject
More informationOral HPV infection and the changing epidemiology in head and neck cancer
Oral HPV infection and the changing epidemiology in head and neck cancer Daniel Beachler, PhD, MHS Johns Hopkins School of Public Health Department of Epidemiology Southwest Region s Dental PBRN Meeting
More informationCancer of the Head and Neck and. HPV Infection. Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic
Cancer of the Head and Neck and HPV Infection Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic Disclaimer I have no relevant financial relationships with the manufacturer(s)
More informationCase Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma
Case Scenario 1 History A 52 year old male with a 20 pack year smoking history presented with about a 6 month history of persistent hoarseness. The patient had a squamous cell carcinoma of the lip removed
More informationAJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx
AJCC Cancer Staging 8 th edition Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx AJCC 7 th edition Lip and Oral cavity Pharynx Larynx KEY CHANGES Skin of head and neck (Vermilion of the lip)
More informationFirst of all, the pathophysiology
Welcome. My name is Eric Sturgis and I m a Professor in Head and Neck Surgery with a joint appointment in the Department of Epidemiology at The University of Texas MD Anderson Cancer Center. And today
More informationOral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi
Oral cancer: Prognosis & Treatment Dr. Hani Al Sheikh Radhi Prognostic factors in Oral caner TNM staging T stage N stage M stage Site Histological Factors Vascular & Perineural Invasion Surgical Margins
More informationEVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH
More informationSimultaneous Integrated Boost or Sequential Boost in the Setting of Standard Dose or Dose De-escalation for HPV- Associated Oropharyngeal Cancer
Simultaneous Integrated Boost or Sequential Boost in the Setting of Standard Dose or Dose De-escalation for HPV- Associated Oropharyngeal Cancer Dawn Gintz, CMD, RTT Dosimetry Coordinator of Research and
More informationHead and Neck Reirradiation: Perils and Practice
Head and Neck Reirradiation: Perils and Practice David J. Sher, MD, MPH Department of Radiation Oncology Dana-Farber Cancer Institute/ Brigham and Women s Hospital Conflicts of Interest No conflicts of
More informationNICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36
Cancer of the upper aerodigestive e tract: assessment and management in people aged 16 and over NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36 NICE 2018. All rights reserved. Subject
More informationCURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER
CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER Jean-Pascal Machiels Department of medical oncology Institut I Roi Albert II Cliniques universitaires Saint-Luc Université catholique de Louvain, Brussels,
More informationWhat is head and neck cancer? How is head and neck cancer diagnosed and evaluated? How is head and neck cancer treated?
Scan for mobile link. Head and Neck Cancer Head and neck cancer is a group of cancers that start in the oral cavity, larynx, pharynx, salivary glands, nasal cavity or paranasal sinuses. They usually begin
More informationCase Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.
More informationSelf-Assessment Module 2016 Annual Refresher Course
LS16031305 The Management of s With r. Lin Learning Objectives: 1. To understand the changing demographics of oropharynx cancer, and the impact of human papillomavirus on overall survival and the patterns
More informationNew Paradigms for Treatment of. Erminia Massarelli, MD, PHD, MS Clinical Associate Professor
New Paradigms for Treatment of Head and Neck cancers Erminia Massarelli, MD, PHD, MS Clinical Associate Professor City of Hope Disclosure Statement Grant/Research Support frommerck Bristol Grant/Research
More informationPhysician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters
Physician to Physician Head and Neck William M. Lydiatt, MD Chair of Surgery Nebraska Methodist Hospital Clinical Professor of Surgery, Creighton University Validating science. Improving patient care.
More informationNEWS A Publication of Vantage Oncology, Tri-State Radiation Oncology Centers - TROC
Congressman Larry Buschon Visits Evansville Cancer Center Nationwide, physicians who provide care to Medicare patients are feeling the impact of significant reimbursement cuts for their services. Members
More informationCase Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of
More informationThe many faces of extranodal lymphoma
The many faces of extranodal lymphoma Frank Pameijer Departments of Radiology and Radiation Oncology University Medical Center Utrecht Special thanks to Ilona M Schmalfuss, MD University of Florida Gainesville,
More informationNasopharynx. 1. Introduction. 1.1 General Information and Aetiology
Nasopharynx 1. Introduction 1.1 General Information and Aetiology The nasopharynx is the uppermost, nasal part of the pharynx. It extends from the base of the skull to the upper surface of the soft palate.
More informationAlberta Head and Neck Cancer Priority Setting Project
Alberta Head and Neck Cancer Priority Setting Project About You 1. Which group best describes you? (Check all that apply). * A person diagnosed with cancer of the head and neck A family member or caregiver
More informationSurvival Benefit of Chemotherapy in Oropharyngeal Cancer Patients Treated with. Surgery and Post-Operative Radiation. Fawaz Mohammed Makki
Survival Benefit of Chemotherapy in Oropharyngeal Cancer Patients Treated with Surgery and Post-Operative Radiation by Fawaz Mohammed Makki A thesis submitted in partial fulfillment of the requirements
More informationESMO Perceptorship H&N cancer Epidemiology, Anatomy and Workup 16 March 2018
ESMO Perceptorship H&N cancer Epidemiology, Anatomy and Workup 16 March 2018 Dr. Victor Ho-Fun Lee MBBS, MD, FRCR, FHKCR, FHKAM (Radiology) Clinical Associate Professor Department of Clinical Oncology
More informationCHAPTER I INTRODUCTION. different sites in the head and neck region. The malignancies in mouth, lip,
1 CHAPTER I INTRODUCTION 1.1.Background of The Study Head and Neck Cancer is a complex of heterogeneous malignancies affecting different sites in the head and neck region. The malignancies in mouth, lip,
More informationHead and Neck Cancer. What is head and neck cancer?
Scan for mobile link. Head and Neck Cancer Head and neck cancer is a group of cancers that usually originate in the squamous cells that line the mouth, nose and throat. Typical symptoms include a persistent
More informationOral Cavity and Oropharynx Cancer Trends
Oral Cavity and Oropharynx Cancer Trends Darien Weatherspoon, DDS, MPH Diplomate, American Board of Dental Public Health Program Officer, National Institute of Dental and Craniofacial Research National
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationSurvey of Laryngeal Cancer at SBUH comparing 108 cases seen here from to the NCDB of 9,256 cases diagnosed nationwide in 2000
Survey of Laryngeal Cancer at comparing 108 cases seen here from 1998 2002 to the of 9,256 cases diagnosed nationwide in 2000 Stony Brook University Hospital Cancer Program Annual Report 2002-2003 Gender
More informationHumaan Papillomavirus en hoofd/halskanker. Pol Specenier
Humaan Papillomavirus en hoofd/halskanker Pol Specenier pol.specenier@uza.be Humaan Papillomavirus en hoofd/halskanker Hoofd/halskanker: incidentie en oorzaken Oropharynx carcinoom Incidentie HPV HPV en
More informationDiagnosis and what happens after referral
Diagnosis and what happens after referral Dr Kate Newbold Consultant in Clinical Oncology The Royal Marsden Women's cancers Breast cancer introduction 1 Treatment Modalities Early stage disease -larynx
More informationBenefits of Genomic Medicine: What to Tell the Patient
Benefits of Genomic Medicine: What to Tell the Patient Christine H. Chung, M.D. Associate Professor of Oncology Director, HNC Therapeutics Program Johns Hopkins University No Conflict of Interest to Disclose
More informationOral Cavity. 1. Introduction. 1.1 General Information and Aetiology. 1.2 Diagnosis and Treatment
Oral Cavity 1. Introduction 1.1 General Information and Aetiology The oral cavity extends from the lips to the palatoglossal folds and consists of the anterior two thirds of the tongue, floor of the mouth,
More informationLocally advanced head and neck cancer
Locally advanced head and neck cancer Radiation Oncology Perspective Petek Erpolat, MD Gazi University, Turkey Definition and Management of LAHNC Stage III or IV cancers generally include larger primary
More informationClinical Trials in Transoral Endoscopic Head &Neck Surgery ECOG3311 and RTOG1221. Chris Holsinger, MD, FACS Bob Ferris, MD, PhD, FACS
Clinical Trials in Transoral Endoscopic Head &Neck Surgery ECOG3311 and RTOG1221 Chris Holsinger, MD, FACS Bob Ferris, MD, PhD, FACS 1 Disclosure I have no conflicts of interest to disclose 2 Robotic H&N
More informationHead and Neck SCC. HPV in Tumors of the Head and Neck. Overview. Role of HPV in Pathogenesis of Head & Neck Tumors
HPV in Tumors of the Head and Neck Christina Kong, M.D. Associate Professor, Stanford Dept of Pathology Director, Cytopathology Laboratory & Cytopathology Fellowship ckong@stanford.edu Head and Neck SCC
More informationCatholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.
Anatomopathology Pathology 1 Anatomopathology Biopsies Frozen section Surgical specimen Peculiarities for various tumor site References Pathology 2 Biopsies Minimum data, which should be given by the pathologist
More informationMANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS
MANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS Kyle Arneson, MD PhD Avera Medical Group Radiation Oncology Avera Cancer Institute 16 th Annual Oncology Symposium September
More informationHeadand neckcancers. Katedra Onkologii Uniwersytet medyczny we Wrocławiu lek. Dominika Zielecka-Dębska, lek. K. Konat, lek. K.
Headand neckcancers Katedra Onkologii Uniwersytet medyczny we Wrocławiu lek. Dominika Zielecka-Dębska, lek. K. Konat, lek. K. Lichoń Headand neckcancers-definition Malignantneoplasmsof theupperpart of
More informationCancer of the upper aerodigestive tract: assessment and management in people aged 16 and over
Cancer of the upper aerodigestive tract: assessment and management in people aged and over NICE guideline Draft for consultation, March 0 This guideline covers This guideline covers assessing and managing
More informationSurgical Margins in Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
Surgical Margins in Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma Consensus update and recommendations, 2018 Head and Neck Steering Committee P. Gorphe *, F. Nguyen, Y. Tao, P. Blanchard,
More informationHPV POSITIVE OROPHARYNGEAL CARCINOMA the radiation oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV POSITIVE OROPHARYNGEAL CARCINOMA the radiation oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium HEAD AND NECK CANCER -HPV Change in incidence: HEAD AND NECK
More informationSurgery in Head and neck cancers.principles. Dr Diptendra K Sarkar MS,DNB,FRCS Consultant surgeon,ipgmer
Surgery in Head and neck cancers.principles Dr Diptendra K Sarkar MS,DNB,FRCS Consultant surgeon,ipgmer Email:diptendrasarkar@yahoo.co.in HNC : common inclusives Challenges Anatomical preservation R0 Surgical
More informationHead and Neck cancer
Head and Neck cancer Medical Oncologist s Role in Multidisciplinary Teams - Focus on Adjuvant & Neo-adjuvant Therapy - Hye Ryun Kim, M.D. Yonsei Cancer Center, Medical Oncology Contents I. Introduction
More informationALL ABOUT HEAD & NECK CANCERS
Organization Accredited by Joint Commission International Certified Medical travel ALL ABOUT HEAD & NECK CANCERS Dr. Sadir Alrawi Director of Surgical Oncology Services Dr. Fatima Al Zahraa Specialised
More informationJOURNAL SCAN FOR IJHNS
JOURNAL SCAN FOR IJHNS IJHNS Journal Scan for IJHNS Meta-analysis of Chemotherapy in Head and Neck Cancer (MACH-NC): An Update on 93 Randomized Trials and 17,346 Patients Jean-Pierre Pignon A, Aurélie
More informationUpdate of the role of Human Papillomavirus in Head and Neck Cancer
Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology
More informationThe International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies
More informationNasopharyngeal Cancer:Role of Chemotherapy
Nasopharyngeal Cancer:Role of Chemotherapy PANAGIOTIS KATSAOUNIS Medical Oncologist IASO GENERAL HOSPITAL Athens, 16/9/2017 2 nd Hellenic Multidisciplinary Conference on Head and Neck Cancer INTRODUCTION
More informationCLINICAL MEDICATION POLICY
CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals
More informationHead & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i
Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &
More informationKatsuro Sato. Department of Speech, Language and Hearing Sciences, Niigata University of Health and Welfare, Niigata, Japan
Report Niigata Journal of Health and Welfare Vol. 12, No. 1 Retrospective analysis of head and neck cancer cases from the database of the Niigata Prefecture Head and Neck Malignant Tumor Registration Committee
More informationOROPHARYNX CANCER. Anthony Zeitouni, MD, FRCSC. Co-Lead, Head Neck Cancer Rossy Cancer Network
OROPHARYNX CANCER Anthony Zeitouni, MD, FRCSC Co-Lead, Head Neck Cancer Rossy Cancer Network CFPC CoI Templates: Slide 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anthony Zeitouni Relationships with commercial
More informationLEUKOPLAKIA Definition Epidemiology Clinical presentation
LEUKOPLAKIA Definition Leukoplakia is the most common premalignant or "potentially malignant" lesion of the oral mucosa. Leukoplakia is a predominantly white lesion of the oral mucosa than cannot be clinicopathologically
More informationRola brachyterapii w leczeniu wznów nowotworów języka i dna jamy ustnej. The role of brachytherapy in recurrent. oral cavity
Rola brachyterapii w leczeniu wznów nowotworów języka i dna jamy ustnej The role of brachytherapy in recurrent tumours of the tongue and fundus of the oral cavity Janusz Skowronek, MD, PhD, Ass. Prof.
More informationIncidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States
Incidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States Louisiana Tumor Registry LSUHSC School of Public Health Lauren Cole, MPH Linda
More informationHPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium DISCLOSURE OF INTEREST Nothing to declare HEAD AND NECK CANCER -HPV
More informationOral Cavity and Pharynx Cancer
Oral Cavity and Pharynx Cancer Figure 18 Definition: Oral cancer begins in the mouth and can include the lips, cheeks, teeth, gums, the floor of the tongue, the roof of the mouth, and the front two-thirds
More informationNasopharyngeal Carcinoma. Rusty Stevens, MD Christopher Rassekh, MD
Nasopharyngeal Carcinoma Rusty Stevens, MD Christopher Rassekh, MD Introduction Rare in the US, more common in Asia High index of suspicion required for early diagnosis Nasopharyngeal malignancies SCCA
More informationImmunotherapy for the Treatment of Head and Neck Cancers. Robert F. Taylor, MD Aurora Health Care
Immunotherapy for the Treatment of Head and Neck Cancers Robert F. Taylor, MD Aurora Health Care Disclosures No relevant financial relationships to disclose I will be discussing non-fda approved indications
More informationAnatomy of Head of Neck Cancer
Anatomy of Head of Neck Cancer J. Robert Newman, MD The ENT Center of Central GA H&N Cancer Overview Most categories of cancer are represented in the H&N Squamous cell carcinoma most common mucosal cancer
More informationOral Cavity Cancer. Oral Cavity. Disclosures. Screening Methods for Early Oral Cancer
Screening Methods for Early Oral Cancer M. Boyd Gillespie, M.D., M.Sc. UCSF Head & Neck Cancer Course San Francisco, CA November 8, 2014 Disclosures Paid consultant & Research Support on sleep apnea devices
More informationCancer of the oropharynx
Cancer of the oropharynx Patient information What is cancer? The human body is made up of billions of cells. In healthy people, cells grow, divide and die. New cells constantly replace old ones in an orderly
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 4/30/2011 Radiology Quiz of the Week # 18 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationGreater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute
2008 ANNUAL REPORT Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute Cancer Registry Report The Cancer Data Management System/ Cancer Registry collects data on all types of cancer
More informationNews Briefing: Thursday, Feb. 20, 7 a.m. MT
News Briefing: Thursday, Feb. 20, 7 a.m. MT Moderator: David aben, MD, ymposium Chair and professor of radiation oncology, University of Colorado Cancer Center, Denver Domiciliary Humidification educes
More informationOral Cavity Cancer Combined modality therapy
Oral Cavity Cancer Combined modality therapy Dr. Christos CHRISTOPOULOS Radiation Oncologist Head and Neck Cancers Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Disclosure slide I have no
More informationTrimodality Therapy for Muscle Invasive Bladder Cancer
Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,
More informationCancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center
Cancer 101 Spring Family Cancer Retreat 4/18/15 Amish Shah, M.D. New Mexico Cancer Center Topics to cover What is Cancer? Screening Diagnosis/Staging Treatment Basics Clinical Trials Surveillance What
More informationEmerging Role of Immunotherapy in Head and Neck Cancer
Emerging Role of Immunotherapy in Head and Neck Cancer Jared Weiss, MD Associate Professor of Medicine and Section Chief of Thoracic and Head/Neck Oncology UNC Lineberger Comprehensive Cancer Center Copyright
More informationRole of the Dental Hygienist in Oral Pathology. Role of the Dental Hygienist in Oral Pathology. Cancers of the Oral Cavity.
Gum Gardeners Study Club April 25, 2016 Early Detection of Oral Cancer Cindy Kleinegger, DDS, MS NW Oral Pathology Tigard, OR nworalpathology.com Role of the Dental Hygienist in Oral Pathology Work closely
More informationPost-Operative Concurrent Chemoradiation with Mitomycin-C for Advanced Head and Neck Cancer
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 2006 Post-Operative Concurrent Chemoradiation with Mitomycin-C for
More information